Jean‐Michel Germain

635 total citations
8 papers, 353 citations indexed

About

Jean‐Michel Germain is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Dermatology. According to data from OpenAlex, Jean‐Michel Germain has authored 8 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Experimental and Cognitive Psychology and 3 papers in Dermatology. Recurrent topics in Jean‐Michel Germain's work include Treatment of Major Depression (4 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (3 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Jean‐Michel Germain is often cited by papers focused on Treatment of Major Depression (4 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (3 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Jean‐Michel Germain collaborates with scholars based in United States, United Kingdom and Italy. Jean‐Michel Germain's co-authors include Karen A. Tourian, B. Pitrosky, Y. Brault, Ulla Lepola, Claudine Brisard, P Boyer, Stuart Montgomery, Enzo Berardesca, C. Paul and Valentina Marino and has published in prestigious journals such as British Journal of Dermatology, Journal of the European Academy of Dermatology and Venereology and European Psychiatry.

In The Last Decade

Jean‐Michel Germain

8 papers receiving 343 citations

Peers

Countries citing papers authored by Jean‐Michel Germain

Since Specialization

Citations

This map shows the geographic impact of Jean‐Michel Germain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Michel Germain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Michel Germain more than expected).

Fields of papers citing papers by Jean‐Michel Germain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Michel Germain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Michel Germain. The network helps show where Jean‐Michel Germain may publish in the future.

Co-authorship network of co-authors of Jean‐Michel Germain

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Michel Germain. A scholar is included among the top collaborators of Jean‐Michel Germain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Michel Germain. Jean‐Michel Germain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Poster 292 Improvement of Spasticity Following AbobotulinumtoxinA (Dysport®) Injections in Shoulder Muscles in Hemiparetic Patients with Upper Limb Spasticity–Sub‐Analysis of a Prospective, Long‐Term, Open‐Label Study with Single and Repeated Injection Cycles 2016 ·PM&R ·Fatma Gül, Michael W. O’Dell, Robert Jech, Marta Banach, Claire Vilain, Anne‐Sophie Grandoulier, Jean‐Michel Germain, Jean‐Michel Graciès	1
2	Pattern of response in patients with moderate-to-severe psoriasis treated with etanercept 2014 ·British Journal of Dermatology ·C.E.M. Griffiths, Wolfram Sterry, (unknown), (unknown), (unknown), Jean‐Michel Germain, Lotus Mallbris	21
3	Retreatment in patients with psoriasis achieving response with etanercept after relapse due to treatment interruption: results from the CRYSTEL study 2014 ·Journal of the European Academy of Dermatology and Venereology ·C.E.M. Griffiths, Thomas A. Luger, Y. Brault, Jean‐Michel Germain, Lotus Mallbris	14
4	A 24-week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis 2012 ·British Journal of Dermatology ·J.‐P. Ortonne, C. Paul, Enzo Berardesca, Valentina Marino, Gaia Gallo, Y. Brault, Jean‐Michel Germain	75
5	An Integrated Analysis of the Efficacy of Desvenlafaxine Compared with Placebo in Patients with Major Depressive Disorder 2009 ·CNS Spectrums ·Michael E. Thase, Susan G. Kornstein, Jean‐Michel Germain, Qin Jiang, Christine J. Guico‐Pabia, Philip T. Ninan	52
6	Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial 2008 ·International Clinical Psychopharmacology ·P Boyer, Stuart Montgomery, Ulla Lepola, Jean‐Michel Germain, Claudine Brisard, (unknown), (unknown), Karen A. Tourian	108
7	An integrated analysis of the efficacy of desvenlafaxine succinate compared with placebo in the treatment of major depressive disorder 2008 ·European Psychiatry ·M.E. Thase, Susan G. Kornstein, Raj Tummala, Jean‐Michel Germain, (unknown), (unknown), Philip T. Ninan	1
8	A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder 2007 ·International Clinical Psychopharmacology ·(unknown), B. Pitrosky, (unknown), Jean‐Michel Germain, Karen A. Tourian	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact